The following data is part of a premarket notification filed by Quinnova Pharmaceuticals with the FDA for Neosalus.
| Device ID | K070309 |
| 510k Number | K070309 |
| Device Name: | NEOSALUS |
| Classification | Dressing, Wound, Drug |
| Applicant | QUINNOVA PHARMACEUTICALS 301SOUTH STATE STREET SUITE NOO1 Newtown, PA 18940 |
| Contact | Jeffrey Day |
| Correspondent | Jeffrey Day QUINNOVA PHARMACEUTICALS 301SOUTH STATE STREET SUITE NOO1 Newtown, PA 18940 |
| Product Code | FRO |
| CFR Regulation Number | 510(k) Premarket Notification [🔎] |
| Decision | Substantially Equivalent (SESE) |
| Type | Traditional |
| 3rd Party Reviewed | No |
| Combination Product | Yes |
| Date Received | 2007-02-01 |
| Decision Date | 2008-09-12 |
| Summary: | summary |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() NEOSALUS 77557887 3677679 Live/Registered |
GLENMARK THERAPEUTICS INC., USA 2008-08-28 |
![]() NEOSALUS 77556490 3677674 Live/Registered |
GLENMARK THERAPEUTICS INC., USA 2008-08-27 |